RxDoctor Payments Data

Joseph Rosado, MD

General Practice · Orlando, FLNPI 1104068584

Payments from drug & device makers

$1,323in general payments, 2019–2025

Across 63 payments — averaging $21.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$265
  • AstraZeneca$165
  • Greenwich Biosciences, Inc.$120
  • Zyla Life Sciences, Inc.$102
  • Collegium Pharmaceutical, Inc.$93
  • Sanofi$89
  • plus $489 from 22 others

What the payments were for

  • Food & beverage$1,323100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,323 in reported general payments places this provider in the 80th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$25,952
Medicare patients
87
Services billed
689

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl37$8,560
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine193$7,236
Methylphenidate Hcl66$1,756
Desvenlafaxine Succinate ErDesvenlafaxine Succinate13$1,346
Alprazolam156$1,218
Cyclobenzaprine Hcl11$1,075
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine41$1,012
Clozapine24$955
Bupropion Hcl SrBupropion Hcl17$948
Amitriptyline Hcl14$712
Venlafaxine Hcl ErVenlafaxine Hcl21$667
Clonazepam66$608
Quetiapine Fumarate42$590
Bupropion XlBupropion Hcl16$545
Duloxetine Hcl23$517

Paid to pharmacies, not to this prescriber.

Other general practice in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →